title: Accurate heterogeneous dose calculation for lung cancer patients without high-resolution CT densities.
abstract: The aim of this study was to investigate the relative accuracy of megavoltage photon-beam dose calculations employing either 5 bulk densities or independent voxel densities determined by calibration of the CT Houndsfield number. Full-resolution CT and bulk density treatment plans were generated for 70 lung or esophageal cancer tumors (66 cases) using a commercial treatment planning system with an adaptive convolution dose calculation algorithm (Pinnacle3, Philips Medicals Systems). Bulk densities were applied to segmented regions. Individual and population average densities were compared to the full-resolution plan for each case. Monitor units were kept constant and no normalizations were employed. Dose volume histograms (DVH) and dose difference distributions were examined for all cases. The average densities of the segmented air, lung, fat, soft tissue, and bone for the entire set were found to be 0.14, 0.26, 0.89, 1.02, and 1.12 g/cc, respectively. In all cases, the normal tissue DVH agreed to better than 2% in dose. In 62 of 70 target DVHs, agreement to better than 3% in dose was observed. Six cases demonstrated emphysema, one with bullous formations and one with a hiatus hernia having a large volume of gas. They required the additional assignment of density to the emphysemic lung and inflammatory changes to the lung, the regions of collapsed lung, the bullous formations, and the hernia gas. Bulk tissue density dose calculation provides an accurate method of heterogeneous dose calculation. However, patients with advanced emphysema may require high-resolution CT studies for accurate treatment planning.
authors.affiliation: Department of Radiation Oncology, University of Florida, Gainesville, FL, U.S.A.|ViewRay Incorporated, Oakwood Village, OH, U.S.A.
authors.forename: Anneyuko I
authors.initials: AI
authors.lastname: Saito
authors.affiliation: Department of Radiation Oncology, University of Florida, Gainesville, FL, U.S.A.
authors.forename: Jonathan G
authors.initials: JG
authors.lastname: Li
authors.affiliation: Department of Radiation Oncology, University of Florida, Gainesville, FL, U.S.A.
authors.forename: Chihray
authors.initials: C
authors.lastname: Liu
authors.affiliation: Department of Radiation Oncology, University of Florida, Gainesville, FL, U.S.A.
authors.forename: Kenneth R
authors.initials: KR
authors.lastname: Olivier
authors.affiliation: Department of Radiation Oncology, University of Florida, Gainesville, FL, U.S.A.|ViewRay Incorporated, Oakwood Village, OH, U.S.A.
authors.forename: James F
authors.initials: JF
authors.lastname: Dempsey
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004307:Dose-Response Relationship, Radiation; D004938:Esophageal Neoplasms / Q000532:radiotherapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011880:Radiotherapy Planning, Computer-Assisted; D014057:Tomography, X-Ray Computed